Last reviewed · How we verify
Transabdominal Plane Block — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Transabdominal Plane Block (Transabdominal Plane Block) — Icahn School of Medicine at Mount Sinai.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Transabdominal Plane Block TARGET | Transabdominal Plane Block | Icahn School of Medicine at Mount Sinai | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Transabdominal Plane Block CI watch — RSS
- Transabdominal Plane Block CI watch — Atom
- Transabdominal Plane Block CI watch — JSON
- Transabdominal Plane Block alone — RSS
Cite this brief
Drug Landscape (2026). Transabdominal Plane Block — Competitive Intelligence Brief. https://druglandscape.com/ci/transabdominal-plane-block. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing